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The mechanism whereby the immune system is rendered unresponsive to self is one 
of the  central  problems  of immunology.  When  natural  tolerance,  which  is  more 
physiological  and  long  lasting  than  any  other  form  of  experimentally  induced 
unresponsiveness  fails,  autoimmune  disease  may  develop.  But  the  mechanism  of 
natural  tolerance has been difficult  to study,  not  only because suitable  models are 
lacking, but also because the presence of the antigen  in  the host  has hampered the 
detection of autoantibodies. In the few models of natural tolerance to soluble protein 
antigens  examined,  for  example  thyroglobulin  or  alpha-fetoprotein,  it  has  been 
suggested that T  cells are unresponsive, whereas B cells are not (1-3). However, these 
antigens circulate in the blood in minute amounts, and the lack of B cell tolerance 
might simply reflect a  difference in dose requirements  for induction  of T-vs.-B cell 
tolerance  (4).  Furthermore,  autoimmunity  to  thyroglobulin,  as studied  in  a  T  cell 
proliferation  assay (5), challenges the state of T  cell  tolerance  to this  T-dependent 
antigen. On the other hand, B cells are known not only to bind autoantigens  (6), but 
also  to  produce  autoantibodies  either  after  immunization  with  cross-reactive  self 
antigens or stimulation with a mitogen such as lipopolysaccharide (2, 3, 7, 8). Whether 
natural  B  cell  tolerance  had  been  broken  or  simply  did  not  occur  is  unclear.  In 
contrast, it is known that both T  and B cells can readily be rendered unresponsive in 
experimentally induced unresponsiveness to either soluble heterologous antigens or to 
haptenated isologous gamma globulin conjugates (4, 9-11). 
Ideally, one should  be able to assess the state of tolerance of immunocompetent 
cells in their environment either with or without  the presence of the antigen  under 
conditions  where  autoimmunity  does  not  normally  occur.  To  fulfill  this  goal,  we 
selected the MUB 1 antigen, which is the murine fifth component of complement C5 
(12).  Murine C5, like its human counterpart  (13), consists of two polypeptide chains 
(14) and has a serum concentration of 50-85 #g/ml (12), which is more than  100-fold 
greater than that of thyroglobulin or alpha-fetoprotein. 
Two strains of mice, B10.D2OSN  (C5 deficient)  and B10.D2NSN  (C5 sufficient), 
are congenic, differing only at the MUB 1 locus. This allows studies of tolerance to C5 
after  reciprocal  transplantation  of  immunocompetent  cells  into  irradiated  hosts 
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without the development of either graft-vs.-host or host-vs.-graft reactions. We used 
two complementary approaches.  In the first, lymphoid cells from either strain were 
transferred into irradiated C5-deficient hosts,  where  detection of anti-C5 antibody 
upon challenge with murine C5 was possible because of the absence of the antigen. 
Second, lymphoid cells from either strain were transferred to irradiated C5-sufficient 
hosts, whose native C5  provided the antigenic stimulus. The results showed  that T 
but not B cells were unresponsive and that the C5 antigen was required to maintain 
unresponsiveness. 
Materials and Methods 
Animals.  Male  6-8-wk-old  B10.D2OSN/J,  B10.D2NSN/J  A/J,  A/HeJ,  C57B1/6J  by 
DBA/2J  (BDF1) mice were obtained from The Jackson Laboratory, Bar  Harbor, ME and 
maintained at the Children's Hospital animal facilities.  On arrival, all B 10.D2 mice received 
water acidified with HC1 to pH 3.0 for 5 d, then tetracycline (Rachelle Laboratories, Long 
Beach,  CA) water for 3 d. Mice that were intended as irradiated hosts were medicated for an 
additional 5 d with acid water plus 20 #g tobramycin/ml before irradiation. 
Antiga~s.  A mouse C5 preparation was obtained from the serum of B 10.D2NSN mice. Male 
B10.D2NSN mice older than 12 wk were used because serum C5 levels rise with age in male 
mice (12). The serum donors were tail bled, and their blood was pooled by pairs and allowed 
to clot at room temperature for ~3 h. After the 3-h clotting time, the serum was centrifuged at 
room temperature and stored at -20°C. The acid euglobulin fraction of this serum, containing 
C5, was prepared as described by Cinader et al. (15). The euglobulin was resuspended in 0.15 
M  phosphate-buffered saline (PBS)/pH  7.0, in a  volume 1/10th that of the original serum. 
The solubilized euglobulin was  combined with  complete Freund's adjuvant  (FCA)  (Difco 
Laboratories, Detroit, MI), and the mice were injected intraperitoneally in a 0.2-ml volume. 
Assuming a minimum C5 concentration of 50/~g/ml of serum, each mouse received ~50 ~g. 
Ovalbumin was purchased from Sigma Chemical Co., St. Louis, MO. Immunizations with 
ovalbumin were with 50 #g injected intraperitoneally in CFA in a final volume of 0.2 ml. 
Radiation  Transfer Protocols.  B10.D2  mice were given a dose of 760-780 rad in a split dose 
from a Cesium Gammacell (General Electric Co., Instruments Products Section, West Lynn, 
MA). Doses were separated from 3-5 h to allow recovery of the gut epithelium but not of the 
bone  marrow.  This  dose  was  lethal  without  reconstitution for  B10.D2OSN  but  not  for 
B 10.D2NSN mice, presumably because of differences in susceptibility  to infection in these mice. 
Cell Preparations for Transfers.  Whole spleen cell suspensions were prepared by washing spleen 
o  6  cells three times in minimal essential medium (MEM)  at 4  C.  70 ×  10  cells were injected 
intravenously per mouse. 
Nonadherent spleen cells were prepared by adherence of whole spleen to Falcon plastic petri 
dishes  (Falcon Labware, Div. of Becton, Dickinson & Co., Oxnard, CA) at a concentration of 
20 ×  10  s cells/ml for 90 min at 37°C in MEM with 2 mM glutamine and 10% fetal bovine 
serum (FBS). The nonadherent cells were removed by gently swirlin~ the plates. These cells 
were further washed three times in MEM as for whole spleen. 70 ×  10  cells were injected per 
mouse. 
Anti-Thy-1.2 plus complement-treated cells were prepared as follows. The viable cells were 
counted and spun into a  pellet. They were resuspended in i  ml of monoclonal anti-Thy-l.2 
(the kind gift of Dr. Ann Marshak-Rothstein) diluted to 1/100 per 250 ×  10  s viable cells. The 
cells were incubated for 30 min on ice, then washed twice in MEM and resuspended in 10 ml 
of guinea pig complement (GPC),  1 part GPC, 3.5 parts MEM plus 10% FBS, and 0.5 parts 
distilled H20 per 250 ×  10  s cells by the original count. The cells were incubated for 45 min at 
37°C. The cells were then washed three times in MEM before injection. 
l Abbreviations used in this paper."  C5, murine fifth component of complement; CFA, complete Freund's 
adjuvant; EACA, epsilon amino caproie acid; FBS, fetal bovine serum; GPC, guinea pig complement; 
GVB, gelatin veronal buffer; MEM, minimum essential medium; PBS, phosphate-buffered saline; PBS- 
BSA, phosphate-buffered saline in bovine serum albumin; RBC, erythrocytes; SRRBC, sensitized rabbit 
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CellFractionation.  Surface Ig+ cells were prepared after Parish (16) as follows. As a separating 
reagent, affinity-purified rabbit anti-mouse immunoglobulin F(ab')2 fragment was prepared. 
The starting material was a rabbit antiserum to the RPC5 tumor product (gamma 2a K). This 
antiserum was shown by immunoelectrophoresis to have specificity for other mouse immuno- 
globulins, including IgM  and IgG1. The  antiserum was  affinity purified on Sepharose  2B 
(Pharmacia Fine Chemicals Inc., Div. of Pharmacia Inc., Piseataway, N  J)  coupled to a  50% 
ammonium sulfate fraction of B10D2OSN serum using the cyanogen bromide technique (17). 
The adsorbed antibody was eluted from the column with 0.2 M  glyeine, pH 2.2. The F(ab')2 
fragment of the affinity-purified  antibody  was generated by digestion with pepsin (Worthington 
Biochemical Corp., Freehold, N  J) in 0.1 M Na acetate buffer, pH 4.55, 20 mg pepsin/g protein. 
The digestion was for 36 h at 37°C. The reaction was stopped by bringing the pH to 8.0 with 
NaOH. The digest was applied to a Sephadex G150 column (dimensions, 75 ×  1.75 cm) run in 
normal saline. No undigested protein was observed, but a  symmetrical peak of F(ab')2 was 
observed, and a sizeable peak of partially digested Fc fragments followed. The F(ab')2 fragment 
containing peak was pooled and used. The F(ab')2 reagent was coupled to sheep erythrocytes 
by the CrCI~ technique (17). The coupled cells were used the day after coupling, after extensive 
washing. Spleen cells to be fractionated by rosetting were washed three times in cold MEM 
and  incubated at  37°C  for  90  min in MEM  with  2  mM  glutamine and  10%  FBS.  This 
incubation was  done to  allow cells  to  shed  passively acquired  immunoglobulin. The pre- 
incubated cells were washed twice in MEM and counted. Rosetting was performed by the 
method of Parker (18). The B cell preparation from the rosetted pellet was only 6% Thy-l.2+; 
the T cell preparation from the interface was 81% Thy-l.2  +. 
Assay of Mouse C5 and Anti-Mouse  C5.  To rapidly, conveniently, and accurately measure 
mouse C5 levels with a high sensitivity, we developed an assay for mouse C5 that uses sensitized 
rabbit erythrocytes as targets, C5-deficient mouse serum as a source of all other complement 
components, and dilutions of normal mouse serum as source of C5. The assay can measure C5 
in dilutions of mouse serum up to  1/200,000, and in human and guinea pig serum at lower 
sensitivity. 
Rabbit erythrocytes were used because mouse spleen serum has been reported to be very 
inefficient in lysis of sensitized sheep erythrocytes (19). We confirmed that observation. We 
therefore  hypothesized  that  rabbit  erythrocytes,  which  are  also  permissive for  alternative 
pathway  lysis  (20),  might  be  a  better  target.  In fact,  C5-sufficient mouse strains do  lyse 
unsensitized rabbit erythrocytes rather well. However, lysis of unsensitized rabbit erythrocytes 
by  fresh  A/HeJ  serum  reconstituted with  small amounts of mouse  C5  was  variable and 
depended on the batch of A/HeJ used.  This variability could be removed by sensitizing the 
rabbit RBC  with a  4-d A/HeJ  anti-rabbit RBC  serum. Thus,  the  variability in lysis was 
probably the result of a lack of natural antibody in some batches of A/HeJ. 
The C5 Assay.  Rabbit RBC stored at 4°C in Alsevier's solution (0.114 M  glucose,  3.2 mM 
Na citrate, 0.012  M  NaCl) were washed four times in gelatin veronal buffer (0.1% gelatin, 5 
mM sodium barbital, 2 mM MgC12, pH  7.3; GVB)  and sensitized with A/HeJ anti-rabbit 
RBC. This antibody was prepared by immunizing  old A/HeJ males with 0.2 ml of 10% rabbit 
RBC in saline intraperitoneally  and bleeding on day 4. The antiserum was titered to determine 
the appropriate concentration. Often very high concentrations were completely inhibitory. The 
optimum sensitizing concentration was always just below the end-point in hemagglutination, 
usually 1/400 and 1/1,000.  For the assay,  1 ml of 1% rabbit RBC was added to 5 ml of antibody 
in GVB at room temperature, mixed, and incubated at room temperature for  15  min. The 
sensitized rabbit RBC (sRRBC) were washed twice in GVB and resuspended to 0.5% in GVB 
for  use.  The cells  were passed through a  21-gauge needle before use,  to disrupt any small 
aggregates that would detract from the accuracy of the assay. A/HeJ males were bled within 
2 h of assay time. The blood was pooled on ice to the desired concentration and allowed to clot 
at 4°C for 30 min. The clot was then spun out at 2,000 rpm for 15 min at 4°C. The serum was 
diluted 1/4 for use in GVB. Serum to be assayed for C5 was obtained within 3 h of assay time. 
The serum was allowed to clot for up to 30 min at room temperature, then until needed at 4°C. 
In the assay,  100/~1 of serum dilution to be tested, 100/~1 of C5-deficient serum (at 1/4), and 60 
#1 of sRRBC (at 0.5%) were combined on ice. The sRRBC were always added last. The assay 
was performed in new 10- ×  75-ram borosilicate tubes (CMS Div., Instrumatics, Inc., Houston, 570  A NATURAL MODEL OF IMMUNOLOGIC  TOLERANCE 
TX). The assay tubes were mixed when complete and incubated at 37°C in a shaker bath for 
1 h. After the incubation, the assay tubes were mixed, spun at 2,000 rpm for 7 min at 4°C, and 
the supernatants removed to dilution tubes as expeditiously as possible. Duplicate supernatants 
were pooled together, using 175 #1 from each tube and 525 #1 of saline. The dilution tubes were 
stored overnight at 4°(3. The optical density at 412 nm was read the following day. Results 
were computed as Z  (sites/cell)  by the formula: Z -  -ln(l -  lysis/total lysis). An optimized 
version of this assay, using EAC14 as target cells, has been described by Ooi et al. (21). 
The AntiC5 Assay.  Inhibition of C5 lytic activity was used as an anti-C5 assay.  The assay 
was performed analogously  to the C5 assay, except that the C5-deficient serum was reconstituted 
with C5 to a starting concentration of 1/25,000 of C5-suffieient mouse serum, and the 100/~1 
of (35 dilution was replaced with  100/~1 of antiserum dilution. The antisera had to be heat 
inactivated (in their dilution of highest concentration at 54°G for 12-15 min to remove active 
complement components. The sera could not be assayed at a concentration higher than 1/25 
because of anticomplementary activity. The anticomplementary activity made it necessary to 
run many normal serum controls, as activity in such sera could range from 0-40% inhibition  at 
1/25. 
Immunodif~ion.  Anti-C5 was also assayed, with much less sensitivity  than the above method, 
by immunodiffusion.  The 1% agar (Difco Laboratories, Detroit MI) was made 0.1 M in epsilon 
amino caproic acid (EACA)  and 10 mM in EDTA (pH adjusted to 7.0). The buffer was 0.025 
M barbital buffer, pH 8.4. To see good precipitin lines, both C5-sufficient serum and antiserum 
had to be applied to the wells twice. Immunoelectrophoresis kits (Gelman Sciences,  Inc., Ann 
Arbor, MI) were used for the immunodiffusions.  In general, any antiserum that produced a line 
in immunodiffusion had >80%  inhibition of C5  hemolytic activity at  1/25.  A  very strong 
antiserum caused detectable inhibition  at 1/2,500. 
Hemagglutination.  Anti-ovalbumin was  assayed by hemagglutination. SRBC were tanned 
with ovalbumin using the CrClz technique. Ovalbumin was used at 0.5 mg/ml. 50 #1 of 2% 
tanned SRBC was added to 50 #1 of antibody solution and the direct titers after mixing and 
settling. The patterns were then washed in 100/tl of diluent and resuspended in 100 #1 of 0.5% 
rabbit anti-mouse immunoglobulin.  The patterns were allowed to reform, and the indirect titer 
was recorded.  Diluent was phosphate-buffered saline, 0.03 M phosphate, 0.15 M NaC1, pH 7.0, 
2.5 mg/ml in bovine serum albumin (PBS-BSA). 
Statistical Analysis.  For C5 inhibition levels and C5 levels, arithmetic means and standard 
deviations were calculated. Individual  positive responses were determined as those values above 
the  mean  plus  two  standard  deviations of the  control  group.  Groups were  compared  by 
Student's t test. 
Results 
C5  Assay.  Fig.  1  shows  the  titrations  of  B10.D2NSN  serum  (homozygous  C5 
sufficient), BDF1 serum (heterozygous C5 sufficient), guinea pig serum, and human 
serum. The assay was most efficient in the detection of mouse C5 activity. BDFa mice 
had approximately one-half the activity of the homozygous strain. The slope of the 
plot of log Z  vs. log C was never >1.1, but, with mouse serum as the source of C5, the 
slope varied from titration to titration, from 0.7 to  1.0. The reason for this variation 
is unknown. The fact  that  the slope did not generally exceed  1.0  indicates that  no 
more  than  one complement component was  titrated.  C5  was  easily detected  at  a 
dilution of 1/200,000 of normal mouse serum. Assuming a concentration of 50/xg/ml 
in serum, this result represents a concentration of 0.25 ng/ml which is the minimum 
detectable by that assay. Serum could not be reliably assayed at concentrations above 
1/10 because of anticomplementary activity. 
Anti-C5 Assays.  Since immunodiffusion does not detect  anti-C5 produced in the 
primary response, inhibition of C5  hemolytic activity was used as a  more sensitive 
assay.  Fig.  2  shows  titrations of early  and late  mouse anti-mouse C5.  By  plotting 
percent specific inhibition (calculated from specific lysis)  vs.  logarithm of antibody D.  E.  HARRIS, L. CAIRNS, F.  S.  ROSEN,  AND Y.  BOREL  571 
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Fzo.  1.  Titrations of various sources of C5 in C5 assay. B10.D2NSN, BDF], human, guinea pig, 
and old A strain mouse serum were all titrated against young A/J mouse serum and sensitized 
rabbit erythrocyte  targets.  Z is plotted on a log scale on the Y axis, and log inverse C5 source 
dilution is plotted on the X axis. 
concentrations, we obtained a  straight line. The slopes of the lines were comparable 
for weak and strong antibody, indicating that the average affinities were similar. An 
extremely strong antiserum  will given detectable inhibition at  1/2,500.  It has  been 
our  experience  that  any  antibody preparation  that  gives >80%  inhibition  at  1/25 
dilution  will  also  produce  a  precipitin  line  in  an  immunodiffusion  assay  vs.  C5- 
sufficient mouse serum. 
Normal sera from C5-deficient and C5-sufficient strains showed a  weak inhibitory 
activity in the anti-C5 hemolysis assay. This activity was observed even when the C5 
in the assay was provided by human serum. At least three normal sera were run with 
each anti-C5 assay to ascertain the level of anticomplementary activity, which varied 
from  assay to  assay.  At  a  dilutiion  of  1/25,  anticomplementary  activities did  not 
exceed 40%  inhibition and were usually less. 50% inhibition was a  significant cut-off 
point for all assays at  1/25.  At  1/50,  the anticomplementary activity fell to <20% 
inhibition. 
Cell  Transfer to  C5-deficient Irradiated Hosts.  To  measure  directly the  capacity  to 
produce anti-C5 of lymphocytes from C5-sufficient mice, we transferred them to C5- 
deficient irradiated hosts,  which  would not  absorb  out  the anti-C5  antibodies, but 
which at the same time would make no response of their own. We therefore ascertained 
three parameters of the transfer system: (a) the ability of C5-deficient lymphocytes to 
respond in irradiated hosts; (b) the extent of transfer of C5 antigen and activity caused 
by transfer of the C5-sufficient immune system; and (c) the inability of the irradiated 
host to respond on its own to C5. 
Ability of C5-deficient Spleen Cells to Respond in Irradiated Hosts 
COMPARISON  WITH  CS-SUFFICIENT SPLEEN CELLS.  Fig.  3  shows  the  primary  and 
secondary responses of C5-deficient irradiated recipients reconstituted with either C5- 572  A  NATURAL  MODEL  OF  IMMUNOLOGIC  TOLERANCE 
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Fro.  2.  Titration of B10.D2OSN anti B10.D2NSN sera by inhibition. An early (after one boost) 
B 10.D2OSN anti-B 10.D2NSN euglobulin antiserum and a late (after four boosts) similar antiserum 
were titrated in the inhibition of B10.D2NSN C5 hemolytic assay. The specific percent inhibition 
of hemolysis is plotted vs. the log inverse dilution of the antibody. The specific percent inhibition is 
obtained by subtracting the percent inhibition of normal B 10.D2OSN serum at each dilution from 
the percent inhibition of the antiserum. 
deficient  or  C5-sufficient  nonadherent  spleen  cells.  In  this  experiment,  the  first 
immunization was administered on day 0, the primary response measured on day 14, 
and  the  second  immunization  was  also  administered  on  day  14.  The  secondary 
response was measured on day 21.  The "NSN-PBS" group is a  control group of C5- 
sufficient into C5-deficient chimeras that have been injected with PBS in CFA. Their 
response is  a  control  for elevation of anticomplementary activity by injection  with 
CFA.  Fig.  4  shows  an  immunodiffusion  test  of  the  same  antisera  shown  in  the 
secondary response in Fig. 3. It is apparent that C5-deficient nonadherent spleen cells 
responded to C5 in this test system. In contrast, C5-sufficient nonadherent spleen cells 
failed to respond. The C5-sufficient spleen cells do generate some inhibitory activity 
above and beyond that of normal C5-deficient serum (the shaded area represents the 
mean inhibitory activity of normal serum plus or minus 2 standard deviations). The 
small amount  of inhibitory activity detected  in  the serum of C5-sufficient  into C5- 
deficient  chimeras  appears  to  be  anticomplementary  activity  generated  even  by 
immunization  with  CFA  alone.  This  experiment  has  been  done  four  times,  with 
similar results. 
In  several  experiments,  the  reconstituted  C5-deficient  hosts  were  injected  with D.  E.  HARRIS,  L.  CAIRNS,  F.  S.  ROSEN,  AND  Y.  BOREL  573 
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Inhibition test of tolerant and nontolerant chimeras against B 10.D2NSN C5. B 10.D2OSN 
C5-deficient  irradiated  hosts  were  reconstituted  with  either  BI0.D2OSN  (nontolerant)  or 
B10.D2NSN  (tolerant) nonadherent spleen cells. The chimeras were immunized with either (25 in 
(2FA  (no notation on figure)  or PBS-(2FA  (as labeled NSN-PBS). OSN is OSN into OSN, NSN is 
NSN into OSN. The first panel is the primary response, measured at a test dilution of 1/25, and the 
second panel is the secondary response, measured at a  test dilution of 1/50. The Y axis is percent 
inhibition of mouse (25 hemolytic activity. The hatched area is the mean -4- 2 SD of normal OSN 
serum tested in the same assays at the same dilutions. 
Fic.  4.  Immunodiffusion test of tolerant and nontolerant chimeras against B10.D2NSN  serum. 
Mice and experiment are as for Fig. 3, panel 2 (secondary response).  Group 1 (I-6), OSN into OSN; 
group 2 (1-6), NSN into OSN. 
ovalbumin  along with  the C5  as  a  specificity control.  Table  I  shows  the response  to 
ovalbumin  by  mice  reconstituted  with  C5-deficient  or  C5-sufficient  nonadherent 
spleen.  The  tolerance  to  C5  was  antigen  specific,  as  both  populations  responded  to 
ovalbumin. 
Lncr  OF TRANSFER OF (25.  C5 is reported to be a  product  of mouse splenic adherent 
cells  (13).  We  therefore removed  the adherent  cells  from our spleen cell preparations 
before  transfer  to  irradiated  CS-deficient  recipients.  The  resulting  chimeras  were 
assayed  for  (25  hemolytic  activity  over  the  course  of several  months.  Hemolytic  (25 
levels in (25-deficient irradiated  hosts that received nonadherent  spleen, whole spleen, 
or bone marrow  of C5-sufficient  donors were less than  10 ng/ml  at all times. 
Despite the lack of evidence of(25 hemolytic activity, the possibility existed that (25 574  A  NATURAL MODEL OF  IMMUNOLOGIC TOLERANCE 
TABLE  I 
Responses of Tolerant and Nontolerant Chimeras of Ovalbumin 
Response  to 
Donor  Host  Antigens 
C5  Ova 
OSN  OSN  C5, Ova  +  +(869 zl: 323) 
NSN  OSN  C5, Ova  -  +(1621  +  870) 
C5-deficient nonadherent  spleen  into C5-deficient irradiated host  (nontoler- 
ant),  and C5-sufficient  nonadherent  spleen  into C5-deficient irradiated host 
(tolerant)  chimeras were immunized on the day of reconstitution with mouse 
C5 and ovalbumin. Ovalbumin titers  were assayed  on day  14. Indirect titers 
only are listed. The enhancing reagent was rabbit anti-mouse immunoglobulin 
at 1/200, absorbed  with SRBC. All test sera were preabsorbed with SRBC. 
TABLE  II 
In  Vivo Absorption of C5 in C5-deficient Chimeras 
Donor  Antibody  Percent 
transferred  inhibition 
--  No  17.6 
OSN  Yes  77.1 
NSN  Yes  78.5 
C5-deficient  B 10.D2OSN irradiated hosts were reconstituted with nonadherent 
spleen  from either B10.D2OSN donors  or C5-sufficient  BI0.D2NSN donors. 
Two of each kind of chimeras were constructed.  On day 3 after reconstitution, 
each mouse was injected with a high titer 50% ammonium sulfate cut of OSN 
anti-NSN C5.  24  h  later,  the  mice were  bled  and  the sera  from  the  two 
duplicate chimeras pooled.  The inhibition of C5 hemolytic activity at a  test 
dilution of 1/25 was measured. 
antigenic  activity had  nonetheless  been  transferred.  To check for this  possibility,  we 
performed an in vivo absorption experiment. Four chimeras were prepared.  Two were 
C5-deficient  recipients  of  nonadherent  C5-deficient  spleen  cells  (as  C5  deficient 
controls),  and  two  were  C5-deficient  recipients  of C5-sufficient  nonadherent  spleen 
cells. On  the 3rd d  after transfer, all four mice were injected with a  high titer anti-C5 
antibody, and the mice were bled the next day. Table II shows the inhibition activities 
in  the  sera  of  these  mice.  There  were  no  differences  in  the  amounts  of  anti-C5 
detectable  in  the  two  pools.  We  conclude  that  there  was  insufficient  C5  antigenic 
activity present in the chimeras to result in absorption of anti-C5 produced in response 
to immunization. 
INABILITY  OF  IRRADIATED HOSTS TO  RESPOND.  Unreconstituted  lethally  irradiated 
animals  eventually  die.  This  death  is  greatly  hastened  by  the  injection  of  CFA. 
However, when mice were given 760 rad in a  split dose and immunized, some survived 
for the requisite  14-20 d  for a  primary response. Unreconstituted  mice as well as bone 
marrow reconstituted  mice and surface Ig-negative spleen cell reconstituted  mice did 
not develop a  primary response to C5 within 20 d, demonstrating  the immunoincom- 
petence of the irradiated  host. 
Cellular  Basis  of  Tolerance.  The  results  shown  in  Figs.  3  and  4  indicate  that 
nonadherent  spleen  of  C5-sufficient  animals  is  tolerant  with  respect  to  antibody 
formation  to  C5.  We  next  determined  whether  T  (nonsurface  immunoglobulin- 
bearing) or B  (surface immunoglobulin-bearing)  cells are responsible for this tolerance. D.  E.  HARRIS,  L.  CAIRNS,  F.  S.  ROSEN,  AND  Y.  BOREL  575 
Fig.  5 shows a compilation of the data obtained from three experiments  in which 
T  cells  and  B  cells  from  C5-deficient  and  C5-sufficient  mice  were  transferred  into 
deficient irradiated hosts. The chimeras were immunized with C5 in CFA on day 0. 
Recipients  of mixed  T  cells  and  B  cells  from the C5-deficient  strain  showed the 
highest percentage of responders to C5. A comparable proportion of chimeras recon- 
stituted  with  C5-deficient  T  cells  and  C5-sufficient  B  ceils  responded.  In  contrast, 
chimeras reconstituted with C5-sufficient T  cells and either C5-deficient or sufficient 
B cells did not respond to C5. From these data, we may conclude that a specific defect 
in the response to C5 occurs in C5-sufficient  T  cells,  as assayed  in the C5-deficient 
irradiated  host.  In  contrast,  B  cells  of the  C5-sufficient  strain  cooperate  with  C5- 
deficient  T  cells  to  produce  a  normal  response  to  C5.  Less  than  25%  of chimeras 
reconstituted with T  or B cells alone responded, indicating that this is a T  and B cell- 
dependent response. 
Table III shows the response to ovalbumin of the chimeras in two of the experiments 
included  in Fig.  5.  All  chimeras reconstituted  with both T  and  B  cells  from either 
strain responded to ovalbumin. It further indicates the specificity of tolerance to C5 
as well as the T  and B cell requirement for the immune response to ovalbumin. 
Cell Transfer to Irradiated C5-sufficient Hosts.  We  next  transferred  C5-deficient  or C5- 
sufficient  nonadherent spleen cells into irradiated C5-sufficient  hosts. The recipients 
were not immunized; instead, their endogenous C5 served as the antigen. The dose of 
radiation  used,  which  was  the  same  as  for  the  C5-deficient  hosts,  was  not  usually 
lethal for the C5-sufficient hosts. 
Fig.  6  shows  a  plot  of the  hemolytic  C5  levels  in  irradiated  C5-sufficient  mice 
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FIG.  5.  Cellular basis of tolerance to C5. C5-deficient B 10.D2OSN irradiated hosts (760 rad) were 
reconstituted with 30-45  ×  10  n sIg  ÷ (B) cells or 30 ×  l0  s sIg- (T) cells or both from C5-sufficient or 
C5-deficient strains, as illustrated in the figure. The chimeras were immunized with more C5 on the 
day of reconstitution, and anti-C5 levels were measured on days 20-24.  Mice whose sera inhibited 
>45%  of stimulated  C5  hemolytic  activity  at  an  antiserum dilution  of  1/25  were  classed  as 
responders. The results shown in this figure are a compilation of three separate experiments. 576  A  NATURAL  MODEL  OF  IMMUNOLOGIC  TOLERANCE 
TABLE  III 
Responses of T plus B Reconstituted C5-deficient (OSN) Irradiated Ch,meras 
to Ovalbumin 
T  B  Average anti-ovalbumin 
titer ±  SE measured on 
(slg-)  (slg  ÷)  day 20 or 24 
OSN  OSN  489.7 ±  371 
ONS  NSN  649 4- 508 
NSN  OSN  671 ±  557 
NSN  NSN  403.2 ±  322 
--  OSN  3.5  ±  21 
ONS  --  2.9 ±  8 
--  NSN  35.5 -i-  101 
NSN  --  9.3 ±  45 
Responses  to  ovalbumin  were  measured  by  indirect  hemagglutination of 
ovalbumin-coated SRBC. The enhancing reagent was rabbit anti-mouse im- 
munoglobulin absorbed with SRBC  at  1/200.  All test antisera were preab- 
sorbed with SRBC. The mice are the same as in Fig. 5. 
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Fro.  6.  Transfer  of C5-deficient spleen  cells into  irradiated C5-sufficient hosts.  80  X  106  C5- 
deficient B10.D2OSN  nonadherent spleen ceils (O)  or 80 ×  10  n C5-sufficient B10.D2NSN  nonad- 
herent spleen cells (0) were transferred into irradiated (760 rad)  B10.D2NSN recipients. C5 levels 
were measured on several days. The Y axis is the percent of normal unirradiated BI0.D2NSN C5 
levels; the X  axis is days after transfer. 
transferred with C5-deficient or C5-sufficient nonadherent spleen cells.  One repre- 
sentative experiment out of five is shown. A dramatic drop in hemolytic C5 activity, 
which starts after day 8, with C5 activity reaching its nadir (10-20% of normal) by 
day 12, then rising abruptly after day 30, occurs in irradiated C5-sufficient recipients 
of nonadherent C5-deficient spleen.  Recipients of C5-sufficient nonadherent spleen D.  E.  HARRIS, L.  CAIRNS, F.  S.  ROSEN, AND Y.  BOREL  577 
ceils as well as unreconstituted or bone marrow reconstituted chimeras  (not shown) 
show only a  minor drop to 70% of normal C5 activity. This drop also occurs at day 
12, but  the C5  activity returns  to normal after about  1 wk. The  mechanism  of this 
radiation-induced drop of C5 activity is unknown. 
C5 is normally present in serum at concentrations of 50-85/~g/ml. A  drop to 20% 
of normal levels means the elimination or inhibition of at least 40 #g/ml of C5. This 
is  much  more  C5  than  is ever  inhibited  in  anti-C5  assays.  In  an  anti-C5  assay,  a 
strong antiserum will inhibit completely a  1/25,000  dilution of normal mouse serum 
at  an  antiserum  dilution of 1/250.  Thus,  such  an  antiserum  at  full strength  could 
only  inhibit  1%  of  normal  C5  activity.  Clearly,  a  very  large  inhibitory  anti-C5 
response would be required  to cause such  a  marked  drop in C5  activity, although 
other mechanisms may be involved. The host cells synthesizing C5 may be affected, 
as they are known to express C5 on their surface (22). 
We next examined the T  and B  cells for tolerance in the presence of C5. We used 
our previously described experimental design, except that  the cells were transferred 
into  irradiated  C5-sufficient  hosts.  The  endogenous  C5  served  as  antigen.  In  the 
experiment shown  in Table IV, recipients of mixed T  and B  cells from C5-deficient 
donors showed a significant drop in C5 activity on both day 12 and day 18. Recipients 
of C5-sufficient T  cells and either C5-deficient or C5-sufficient B  cells did not show 
any drop in C5 activities at any time. Recipients of T  cells or B  cells alone did not 
show significant drops in C5 activities. 
As  both  T  and  B  cells are  required  to  produce  a  drop  in  C5  activity in  these 
irradiated C5-sufficient recipients, we may conclude that this response is both T  and 
B  dependent  and  so must  require antibody. On  day  12,  either C5-deficient or C5- 
sufficient  donor  B  cells cooperated  with  C5-deficient  T  ceils to  cause  comparable 
drops in C5 activity. This result confirmed our previous observation of lack of B  cell 
tolerance in the C5-deficient hosts. By day 18, the C5 activity had largely returned to 
TABLE IV 
Cellular Basis of Tolerance to C5 in CS-sufficient Hosts (NSN) 
Donor cells  Percent reduction of C5 activity 
T cells  B cells  Day 12  Day 18 
OSN  OSN  38*  52:~ 
OSN  NSN  34§  12 
NSN  OSN  0  0 
NSN  NSN  0  0 
OSN  --  11  9 
--  OSN  0  0 
NSN  --  0  0 
C5-sufficient BI0.D2NSN irradiated hosts (760 rad) were reconstituted with 
either 35 ×  108 sIg  + (B) cells or 28 ×  106 slg- (T) cells or both from C5- 
sufficient or C5-deficient strains, as illustrated in the table. Hemolytic C5 
activity was measured  12 and 18 d after cell transfer. The percent reduction 
in C5 activity below that of unreconstituted  controls is listed. The P values 
refer to the comparison between the indicated groups and the unreconstituted 
control as compared by Student's t test. No other groups were statistically 
different from the controls. 
* 0.010 < P < 0.025. 
~: 0.001 < P< 0.005. 
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normal in the recipients of C5-sufficient B  cells and C5-deficient T  cells, whereas C5 
activities continued  to fall in recipients of C5-deficient T  and  B  cells. As predicted 
from  the experiments  in C5-deficient hosts,  recipients of T  cells from  C5-sufficient 
donors were tolerant. 
Maintenance  of Tolerance.  The transfer into C5-deficient host system also allows us 
to examine the question of maintenance of tolerance. How long after transfer does the 
tolerance last, and what is the influence of externally supplied antigen on the duration 
of tolerance? 
Table V  shows the timing of the loss of tolerance in irradiated C5-deficient hosts 
reconstituted with C5-sufficient nonadherent spleen cells. It is seen that by 28 d  after 
reconstitution, two immunizations with C5 resulted in 70% of chimeras that responded 
to C5.  Primary responses to immunization at day 28 were, in general, poor, both in 
recipients of C5-sufficient or C5-deficient cells. 
The basis for the loss of tolerance by day 28  is unknown.  Two  possibilities exist. 
The C5-deficient host could have recovered, or the C5-sufficient reconstituting cells 
could simply have lost tolerance in the absence of antigen. We have results suggesting 
that  the  first  possibility is  correct.  Table  VI  shows  the  survival  figures  for  mice 
reconstituted either with  5  ×  105  anti-Thy-l.2-treated bone marrow cells or nonad- 
herent C5-sufficient spleen, immunized twice starting on day 28 after reconstitution. 
Although the bone marrow dose was not sufficient to reconstitute most of the mice, 
many  of the  surviving  mice  responded  to  C5.  As  shown  by  the  average  percent 
inhibition of C5,  many responded better than  mice reconstituted with C5-sufficient 
TABLE V 
Loss of Tolerance in C5-sufficent (NSN) into C5-deftcient (OSN) Irradiated 
Host Chimeras 
Day of first immunization 
0  12  28 
OSN ~  OSN  100%  100%  100% 
NSN ---* OSN  0%  0%  60-80% 
C5-sufficient nonadherent  spleen into C5-deficient irradiated host chimeras 
were immunized  at various times after reconstitution.  The percent  of mice 
responding >50% inhibition after two immunizations  is given. Data for C5- 
deficient nonadherent  spleen into C5-deficient irradiated hosts are given for 
comparison. 
TASLE VI 
Host Response after 28 d 
Survival  Average percent 
Donor  Host  inhibition 
(day 49)  of C5 
OSN bone marrow  OSN  7/28  54.1 -I- 26.58 
NSN spleen  OSN  6/9  23.37 +  1.46 
C5-deficient  irradiated  hosts  were  reconstituted  with  either  70  ×  l0  s 
B10.D2NSN C5-sufficient nonadherent  spleen cells or 5 ×  106 B10.D2OSN 
anti-Thy-1.2 plus complement-treated bone marrow (minimum reconstitution) 
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spleen  cells,  which  responded  poorly in  this  instance.  Because  the  bone  marrow 
recipients respond, we suspect that the irradiated host recovers before day 28, causing 
a response to C5. 
Whatever the cause of  the loss of tolerance, the question of maintenance of tolerance 
by antigen is still important. Table VII shows the results of an experiment in which 
the C5-sufficient donor ceils were transferred to 125-deficient irradiated recipients and 
the chimeras given an immunizing dose of C5  at  various times before day 28.  For 
comparison, results with C5-deficient donor cells are also given. These times were day 
10 (,pre-immunized NSN donors), day 0, and day  12 (in the C5-deficient host). The 
immunizations on day 0 or on day 12 maintained tolerance, such that two immuni- 
zations starting on day 28 did not result in a response to C5. Mice immunized starting 
on day 0 or day 12 and continuously immunized every 2 wk thereafter also remained 
tolerant for several months (results not shown). These results indicate that the presence 
of antigen  is required to maintain  tolerance. They also show that  antigen in CFA 
maintains tolerance. 
Discussion 
We examined natural immunologic tolerance to an autologous soluble antigen in 
congenic strains of mice characterized by either the presence or the absence of (35. 
The two main  findings were that  tolerance was  mediated by T  cells and  that  the 
antigen  was  necessary to maintain  tolerance. Before discussing the  implications of 
these  observations,  it  is  essential  to  recall  some  of  the  unique  features  of  this 
experimental model because they have a  direct bearing on the interpretation of the 
data. A number of reasons make this system particularly relevant for the study of self 
tolerance. First,  the antigen 125  is  well characterized, a  two chain disulfide linked 
glycoprotein with  a  serum  concentration of 50-85 #g/ml  and  a  206,000  mol  wt, 
slightly larger than  immunoglobulin,  the  tolerogen par excellence. Second, highly 
sensitive  assays  were  developed to  determine  the  presence  of 125  and  anti-125  by 
hemolytic activity and inhibition of same. These assays detected minute quantities of 
antigen  after cell transfer and  could  monitor the  change  of serum  C5  activity in 
irradiated C5-sufficient chimeras. Third, B 10.D2OSN (125 deficient) and B 10.D2NSN 
(C5 sufficient) strains of mice, because they are congenic, permit us to examine not 
Donor 
TABLE  VII 
Maintenance of Tolerance by Antigen in CFA 
Day of immunization 
0  12  28:1:42 
Percent 
responding 
at day 49 
NSN  --  --  Yes  72 
NSN  --  Yes  Yes  0 
NSN  Yes  --  Yes  16.7 
Preimmunized  --  --  --  83 
NSN 
OSN  --  --  Yes  100 
C5-sufficient into C5-deficient irradiated host chimeras were immunized  with 
mouse C5 at various times before and during the  1st mo after reconstitution. 
The preimmunized donors were immunized with mouse C5 10 d  before killing, 
with the response measured on day 49. The percent of mice responding above 
50% at a  test dilution of 1/25 are given. 580  A NATURAL MODEL OF IMMUNOLOGIC TOLERANCE 
only the immunocompetence of the lymphoid cells in irradiated hosts of either strain, 
without  graft-vs.-host or host-vs.-graft reaction,  but  also whether cells of putatively 
tolerant animals were unresponsive either in the presence of the antigen in its native 
form or, more importantly, in its absence. 
A  suitable positive control was provided by irradiated  C5-deficient hosts repopu- 
lated with syngeneic nonadherent spleen cells and challenged with C5 in CFA. Both 
cell  repopulation  and  immunization  were  necessary  to  produce  anti-C5  antibody 
detectable  by  the  hemolytic  inhibition  assay.  In  the  secondary  response,  anti-C5 
antibody activity was also detectable by immunodiffusion. In contrast,  C5-deficient 
irradiated recipients of C5-sufficient nonadherent  spleen cells failed to produce anti- 
C5 antibody activity both in the primary and the secondary response.  Because this 
tolerance can be adoptively transferred  by lymphoid cells into  irradiated  congenic 
hosts and does not affect the response to ovalbumin, it is antigen  specific. Further, 
this tolerance represents central unresponsiveness, as no antigen  carryover could be 
detected either by hemolytic assay or in vivo absorption. 
The model  further  demonstrated  that  tolerance  to C5  was mediated  by T  cells. 
This was observed both in irradiated C5-sufficient and C5-deficient hosts repopulated 
with mixtures of T  and B  cells. The finding that T  cells were tolerant  to a  soluble 
native antigen is consistent with previous data (1-3, 23) and confirmed the observation 
that only one cell type needs to be unresponsive for an animal to be tolerant to a T- 
cell-dependent antigen  (4).  In this paper, we have not examined which subsets of T 
cells are unresponsive. For example, it is unknown whether C5 renders helper T  cells 
unresponsive directly or whether unresponsiveness is mediated by suppressor T  cells 
or their soluble products.  Alternatively, both suppressor T  cells and  helper T  cells 
specifically tolerant to C5 might be present, but the former are not necessarily related 
to the latter. In support of this view is the observation that two different forms of the 
same antigen can elicit either suppressor T  cells or tolerance (24)  and that there is a 
dichotomy in the cellular mechanism of these two distinct forms of unresponsiveness 
(25). 
The fact that B cells were not tolerant to C5 is perhaps more intriguing,  not only 
because  it  raises  questions  about  the  susceptibility  of tolerance  in  T-vs.-B cells  to 
autologous antigens,  but  also because it challenges  the clonal  abortion  hypothesis, 
which postulates that B cells are irrevocably tolerized by self antigens early in their 
maturation. B ceils might be responsive either because of the nature of the antigen or 
because of insufficient dose. Whereas antigens with multiple epitopes are particularly 
effective for B  cell tolerance  (26),  there is no known soluble antigen  that  is able to 
render T but not B cells tolerant because of its structure only. The serum concentration 
of C5  (at  50 #g/ml)  might  be  insufficient  to  induce  B  cell  tolerance,  though  this 
concentration  is  known  to  induce  B  cell  tolerance  to  heterologous  gammaglobulin 
either in vitro  (27,  28)  or in utero  (29).  Because it is known  that  neonatal  cells are 
more susceptible than  adult  cells  to  tolerance  induction  (30)  and  because the C5- 
sufficient mice had been exposed neonatally to C5, it is unlikely that the lack of B cell 
tolerance  is  due  to  the  level of tolerogen.  In  autoimmunity,  B  cells  are  known  to 
respond to autoantigens (31). Mitogens also, such as lipopolysaccharides, can stimulate 
B cells to produce autoantibody (8). Nonetheless, these findings are difficult to extend 
to physiologic B cell responsiveness to native soluble antigens of relatively high serum 
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host complicates the issue. For example, studies on the specificities of antibodies to 
hemoglobin  (32), cytochrome (33),  and  insulin  (34)  have been  done,  but  in  these 
studies the extent to which antibody is absorbed by native antigens was ignored. The 
transfer of spleen cells into irradiated C5-sufficient mice allows us to observe tolerance 
in the presence of the native antigen in its original distribution. When C5-deficient 
spleen cells are transferred, a  massive drop in C5 level occurs. In contrast, sufficient 
spleen cells do not  mediate this drop.  Because the  drop  in  C5  levels required the 
participation of both T  and B cells, it suggests that it is antibody dependent. This is 
the only system using normal cells in which tolerance in the presence of the antigen 
may be reliably observed. 
One of the leading theories of natural tolerance is the clonal deletion hypothesis 
(35,  36), further refined to clonal abortion (37). This theory postulates that  B cells, 
during  differentiation,  while  they  acquire  immunoglobulin  on  their  surface,  pass 
through a stage in which they are particularly susceptible to tolerance induction. As 
a consequence, immunoglobulin-bearing B cells able to react to tolerogen should be 
absent.  The  finding  that  mature  C5-sufficient splenic  cells separated  by virtue of 
surface  immunoglobulin  respond  to C5  is  in  direct  contradiction with  the  clonal 
abortion hypothesis. This argument is further strengthened by our preliminary results 
that suggest that B cells are not tolerant, even in the C5-sufficient irradiated host. But 
the clonal abortion hypothesis, which might apply to acquired unresponsiveness of 
antigen with repeated epitopes, has not been tested for a natural antigen. Some even 
have questioned whether B cell tolerance to natural antigen exists (38). On the other 
hand,  it  is  conceivable  that  a  subset  of B  cells  might  be  tolerant  to  C5,  but 
unresponsivess in  this subset  is  masked  by the  response of the  large proportion of 
mature  B  cells.  But whether physical or functional  deletion occur, as proposed in 
clonal anergy (39), might be difficult to prove or disprove. 
Finally, the role of the antigen in the maintenance of unresponsiveness should be 
emphasized in this physiological model of tolerance. The form of antigen required 
and  the duration of tolerance are both of interest.  In C5-deficient irradiated mice 
reconstituted with C5-sufficient spleen cells, tolerance spontaneously wanes  after  1 
mo. It is unclear whether tolerance was broken or spontaneously waned, but we favor 
the latter interpretation. When C5-deficient irradiated hosts were repopulated with a 
minimum dose of bone marrow cells, insufficient to enable the host to respond to C5 
when they had been immunized immediately after cell reconstitution, they form anti- 
C5 antibody when challenged  1 mo later, suggesting that we are dealing not with a 
donor,  but  rather  a  host-immune  response.  On  the  other  hand,  it  is  clear  that 
administration of C5 in CFA, either on the day of cell transfer or 12 d later, maintains 
unresponsiveness.  In  addition,  repeated injections of C5  in CFA maintained  unre- 
sponsiveness for several months. Although the cellular mechanism of the maintenance 
of tolerance is unknown, it seems paradoxical that antigen in CFA, the immunogenic 
form, is, in fact, tolerogenic. In contrast, C5 in its native form in the C5-sufficient host 
can be immunogenic. This paradox suggests that in this natural model of tolerance, 
the form of the antigen is not the direct determinant of the type of response by the 
immune system. It shows that the antigen is necessary not only to induce tolerance 
but also to maintain it. Thus, natural tolerance to C5 appears to be an active process, 
dependent upon both the presence of the antigen as well as T  cells. In contrast, the 582  A NATURAL MODEL OF  IMMUNOLOGIC TOLERANCE 
capacity to produce autoantibody by B cells from tolerant or nontolerant hosts in the 
presence or absence of antigen appears to remain unimpaired. 
Summary 
A  unique experimental model is described, where natural  immunologic tolerance 
to a well-defined soluble native antigen  (murine C5)  is examined in congenic strains 
of mice that  differ only by the  presence  or  the  absence of C5.  A  highly  sensitive 
hemolytic assay was developed to detect nanogram amounts of C5 as well as an assay 
of anti-C5  inhibition  of C5  hemolytic activity. The  latter was more sensitive  than 
immunodiffusion. Two reciprocal approaches were used to study the cellular basis of 
tolerance in irradiated  hosts of either strain.  In the first, lymphoid cells from either 
strain were transferred to irradiated B10.D2OSN  hosts that were lacking C5 and so 
would  not  hinder  detection  of anti-C5  antibody  upon  challenge  with  murine  C5. 
Second, lymphoid cells from either strain were transferred to irradiated B 10.D2NSN 
hosts,  whose  native C5  provided  the  antigenic  stimulus.  The  immune  response of 
whole  nonadherent  spleen  cell  suspension  as  well  as  mixtures  of T  and  B  cells 
(separated on the basis of surface immunoglobulin)  from either strain were studied. 
In addition, the duration of tolerance and the antigen requirement to maintain it in 
irradiated C5-deficient hosts repopulated with C5-sufficient spleen cells was examined. 
The positive control  of irradiated  C5-deficient  hosts  repopulated  with  syngeneic 
spleen cells showed a  primary and secondary response to immunization. In contrast, 
C5-sufficient  spleen  cells  failed  to respond  both  in  the  primary and  the secondary 
response. Because the unresponsiveness was not caused by antigen carryover and was 
not antigen specific, it represents central tolerance.  In C5-sufficient irradiated  hosts 
(where immunization was not required and antigen was present in natural form and 
physiological  concentration),  transfer  of C5-deficient  cells  mediated  a  drop  in  C5 
levels  to  10-20%  of that  noted  in  unreconstituted  controls.  T  and  B  cell  mixing 
experiments from the two strains into deficient or sufficient hosts demonstrated that 
tolerance  is  T  cell  dependent  and  that  C5-sufficient  or  -deficient  B  cells  could 
cooperate  with  nontolerant  C5-sufficient  T  cells  to  produce  significant  anti-C5 
antibody  or  mediate  a  significant  drop  in  C5  levels.  In  addition,  the  presence  of 
antigen was necessary to maintain tolerance. 
In conclusion, these results show that (a) natural tolerance to C5 is an active process 
that  is T  cell  dependent  and  requires  the  presence  of antigen;  (b)  in  this  natural 
model, clonal abortion does not seem to occur; and (c) both tolerant and nontolerant 
B cells retain the capacity to produce autoantibody. 
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